Smith, Alexander E <br/><br/>
Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.  [electronic resource] 

 -  Blood  Nov 2010 
 - 3923-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2010-03-274704  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Amino Acid Substitution<br/>Base Sequence<br/>Cell Differentiation--genetics<br/>DNA Mutational Analysis<br/>DNA-Binding Proteins--genetics<br/>Dioxygenases<br/>Female<br/>Gene Expression<br/>Humans<br/>Janus Kinase 2--genetics<br/>Karyotyping<br/>Leukemia, Myelomonocytic, Chronic--genetics<br/>Loss of Heterozygosity<br/>Male<br/>Middle Aged<br/>Molecular Sequence Data<br/>Mutation<br/>Myelodysplastic Syndromes--genetics<br/>Polymorphism, Single Nucleotide<br/>Prognosis<br/>Proto-Oncogene Proteins--genetics<br/>RNA, Messenger--genetics<br/>RNA, Neoplasm--genetics<br/>Survival Analysis<br/>T-Lymphocytes--metabolism<br/>Young Adult